LAZERTINIB vs LEMBOREXANT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LAZERTINIB vs LEMBOREXANT: Safety Overview
| Metric | LAZERTINIB | LEMBOREXANT |
|---|---|---|
| Total FAERS Reports | 352 | 989 |
| Deaths Reported | 15 | 44 |
| Death Rate | 4.3% | 4.4% |
| Hospitalizations | 83 | 278 |
| Average Patient Age | 66.6 yrs | 58.9 yrs |
| % Female Patients | 59.9% | 63.4% |
| FDA Approval Date | Aug 19, 2024 | Apr 7, 2020 |
| Manufacturer | Janssen Biotech, Inc. | Eisai Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |